Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,635 | 228,805 | 240,335 | 382,761 | 310,676 |
| Marketable Securities | 196,578 | 360,643 | N/A | N/A | N/A |
| Receivables | 24,024 | 15 | N/A | N/A | N/A |
| Inventories | 33,209 | 4,138 | N/A | N/A | N/A |
| TOTAL | $435,915 | $660,929 | $275,302 | $425,771 | $346,952 |
| Non-Current Assets | |||||
| PPE Net | 63,563 | 49,553 | 34,862 | 35,209 | 33,541 |
| Intangibles | 19,809 | 12,373 | 0 | 0 | 65 |
| Other Non-Current Assets | 69,781 | 59,870 | 65,217 | 29,294 | 25,002 |
| TOTAL | $153,153 | $121,796 | $100,079 | $64,503 | $58,608 |
| Total Assets | $589,068 | $782,725 | $375,381 | $490,274 | $405,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,083 | 1,969 | 103 | 531 | 431 |
| Accrued Expenses | 55,792 | 52,276 | 39,581 | 40,797 | 23,667 |
| Other current liabilities | 10,000 | 3,500 | N/A | N/A | N/A |
| TOTAL | $73,440 | $60,743 | $44,737 | $46,366 | $28,551 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 337,499 | 294,657 | 171,256 | 145,234 | 63,689 |
| TOTAL | $337,499 | $294,657 | $219,170 | $145,234 | $63,689 |
| Total Liabilities | $410,939 | $355,400 | $263,907 | $191,600 | $92,240 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 266,129 | 174,101 | N/A | N/A |
| Common Shares | 12 | 12 | 8 | 8 | 4 |
| Retained earnings | -1,386,752 | -1,099,224 | -878,562 | -670,179 | -521,340 |
| Other shareholders' equity | -5,238 | -29,056 | -28,874 | -38,780 | -8,452 |
| TOTAL | $178,129 | $427,325 | $111,474 | $298,674 | $313,320 |
| Total Liabilities And Equity | $589,068 | $782,725 | $375,381 | $490,274 | $405,560 |